Author of the publication

Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders

, , , , , , , , , and . Pediatrics, 130 (Suppl 2): S125-38 (November 2012)Review; NLM Journal Code: oxv, 0376422.

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Use of Psychotropic Medications in Autism Spectrum Disorders (ASD): An Autism Treatment Network Study, , , and . (2011)Medical Conditions and Demographic, Service and Clinical Factors Associated with Atypical Antipsychotic Medication Use Among Children with An Autism Spectrum Disorder, , , , , and . Journal of Autism and Developmental Disorders, (2017)Prevalence of Creatine Deficiency Syndromes (CDS) and impact of genotypic variability of CDS genes in children with Autism Spectrum Disorder (ASD), , , , , , , and . (2013)Characterizing Inscapes and resting-state in MEG: Effects in typical and atypical development., , , , and . NeuroImage, (2021)Examining the effect of chronic intranasal oxytocin administration on the neuroanatomy and behavior of three autism-related mouse models., , , , , , , , and . NeuroImage, (2022)Factors associated with psychotropic medication use in ASD, , , , and . (2011)Systematic comparisons of different quality control approaches applied to three large pediatric neuroimaging datasets., , , , , , , , , and 10 other author(s). NeuroImage, (July 2023)Use of psychotropic medication in children and adolescents with autism spectrum disorders., , , , , , , and . Pediatrics, 130 (Suppl 2): S69-76 (November 2012)NLM Journal Code: oxv, 0376422.Side effect monitoring of children with ASD prescribed Second Generation Antipsychotics (SGAs), , , , , , , , and . (2011)Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders, , , , , , , , , and . Pediatrics, 130 (Suppl 2): S125-38 (November 2012)Review; NLM Journal Code: oxv, 0376422.